Waldenström's macroglobulinemia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Waldenström's macroglobulinemia}} | {{Waldenström's macroglobulinemia}} | ||
{{CMG}} | {{CMG}}{{AE}}{{MGS}} | ||
==Overview== | ==Overview== | ||
Stem cell transplant is used when lymphoma relapses or is refractory to the medical therapy. <ref name="surg">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015)http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | [[Stem cell transplant]] is used when lymphoma relapses or is refractory to the medical therapy. <ref name="surg">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015)http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | ||
==Surgery== | ==Surgery== | ||
[[Stem cell transplant]] is used when lymphoma relapses or is refractory to the medical therapy. <ref name="surg">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015)http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | |||
==References== | ==References== | ||
Revision as of 00:48, 7 January 2016
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia surgery On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia surgery |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Stem cell transplant is used when lymphoma relapses or is refractory to the medical therapy. [1]
Surgery
Stem cell transplant is used when lymphoma relapses or is refractory to the medical therapy. [1]
References
- ↑ 1.0 1.1 Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015)http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015